• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYP 0.00% 21.0¢

CYNATA THERAPEUTICS LIMITED

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and... Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CYP
Going forward...
34 35 36
18/04/24 2.1K 673K
18/04/24 Last post  gavint66 Comments Created with Sketch.  2.1K  Views Created with Sketch.  673K 
CYP 17/04/24 4 667
17/04/24 Last post  JB1975 Comments Created with Sketch.  4  Views Created with Sketch.  667 
CYP 17/04/24 22 4.4K
TRENDING NEWS

Crypto world awaits overnight Bitcoin halving event

NEWS
19 Apr 2024
17/04/24 Last post  Pledge Comments Created with Sketch.  22  Views Created with Sketch.  4.4K 
CYP
Timelines
15/04/24 4 969
15/04/24 Last post  viewph Comments Created with Sketch.  4  Views Created with Sketch.  969 
CYP 05/04/24 226 53K
05/04/24 Last post  JabraD Comments Created with Sketch.  226  Views Created with Sketch.  53K 
CYP 05/04/24 61 10K
05/04/24 Last post  pfeifer1982 Comments Created with Sketch.  61  Views Created with Sketch.  10K 
CYP 22/03/24 8 1.4K
22/03/24 Last post  OceanView Comments Created with Sketch.  8  Views Created with Sketch.  1.4K 
CYP
The Phase I/IIb Nereid Study Is Now Registered
22/03/24 19 3.0K
22/03/24 Last post  truss20 Comments Created with Sketch.  19  Views Created with Sketch.  3.0K 

See All Discussions arrow Created with Sketch.

Timeline

Notification regarding unquoted securities - CYP
17 Apr 13:36
 
DFU Clinical Trial Enrolment Complete
08 Apr 08:58
 
EU Approval for Phase 2 CYP-001 Trial in GvHD
20 Mar 08:55
 
Cynata Presenting at Advanced Therapies Congress
18 Mar 08:52
 
First Patient Treated in Phase 2 GvHD Trial
05 Mar 08:54
 
Cynata Appoints New Chief Business Officer
29 Feb 09:19
 
View More arrow Created with Sketch.
(20min delay)
Last
21.0¢
Change
0.000(0.00%)
Mkt cap ! $37.72M
Open High Low Value Volume
21.0¢ 21.5¢ 20.5¢ $32.14K 154.2K

Buyers (Bids)

No. Vol. Price($)
1 1481 21.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.5¢ 12183 2
View Market Depth
Last trade - 16.10pm 19/04/2024 (20 minute delay) ?
Last
20.5¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
21.0¢ 21.0¢ 20.5¢ 7899
Last updated 14.56pm 19/04/2024 ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.